Related Articles
Ezetimibe prevents the development of non‑alcoholic fatty liver disease induced by high‑fat diet in C57BL/6J mice
Fatty liver and alteration of the gut microbiome induced by diallyl disulfide
Berberine protects against diet-induced obesity through regulating metabolic endotoxemia and gut hormone levels
Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice
Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic‑associated fatty liver disease in mice